---
layout: post
title: "泽璟制药：盐酸杰克替尼片用于治疗重型新冠患者的临床试验申请获得受理"
date: 2022-05-31 19:11:17 +0800
categories: cailianshe
tags: 财联社新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.688266" data-code="688266|1|1" data-code2="688266|1|23|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.688266&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 688266_0" data-code="K 688266|1|1" data-code2="K 688266|1|23|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>泽璟制药公告，公司近日收到国家药监局核准签发的《受理通知书》，公司自主研发的盐酸杰克替尼片用于治疗重型新型冠状病毒肺炎患者的临床试验申请获得受理。</p><p class="em_media">（文章来源：财联社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202205312398087258>

[返回财联社新闻](//finews.withounder.com/category/cailianshe.html)｜[返回首页](//finews.withounder.com/)